Get access

Maintenance therapies for multiple myeloma

  • Protocol
  • Intervention

Authors

  • Helen Georgiev,

    Corresponding author
    1. University of South Florida, Center for Evidence Based Medicine and Health Outcomes Research, Tampa, Florida, USA
    • Helen Georgiev, Center for Evidence Based Medicine and Health Outcomes Research, University of South Florida, 12901 Bruce B. Downs Blvd MDC 27, Tampa, Florida, 33612, USA. hgeorgie@health.usf.edu.

    Search for more papers by this author
  • Ambuj Kumar,

    1. University of South Florida, Center for Evidence Based Medicine and Health Outcomes Research, Tampa, Florida, USA
    Search for more papers by this author
  • Rahul Mhaskar,

    1. University of South Florida, Center for Evidence Based Medicine and Health Outcomes Research, Tampa, Florida, USA
    Search for more papers by this author
  • Branko Miladinovic,

    1. University of South Florida, Center for Evidence Based Medicine and Health Outcomes Research, Tampa, Florida, USA
    Search for more papers by this author
  • Keith Wheatley,

    1. University of Birmingham, Cancer Research UK Clinical Trials Unit, School of Cancer Sciences, Birmingham, UK
    Search for more papers by this author
  • Benjamin Djulbegovic

    1. Center for Evidence Based Medicine and Health Outcomes Research, University of South Florida, Professor of Medicine and Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

Our overall objectives are to perform a systematic review of maintenance therapies in patients with MM to assess benefits (OS, PFS, response, and quality of life) and harms (adverse events and treatment-related mortality) among patients with MM. Furthermore, if maintenance therapy is beneficial, which regimen is the most optimal.

Ancillary